Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Allergan Targets Strides, Agila Over Generic Eye Drops
Law 360
Saturday, May 18, 2013 - 12:51pm
tags:
Allergan, Strides Arcolab, Agila, Zymar, Zymaxid, conjunctivitis, generics
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Saturday, May 18, 2013 - 12:24pm
tags:
JNJ, Bristol-Myers Squibb, Watson Pharmaceuticals, Repros Therapeutics
Aveo Pharmaceuticals, Inc. Sued by Investor
Sacramento Bee, CA
Saturday, May 18, 2013 - 12:21pm
tags:
Aveo Pharmaceuticals
Acura Pharmaceuticals Is Grossly Undervalued And Poised For Rapid Growth
Seeking Alpha
Saturday, May 18, 2013 - 12:19pm
tags:
Acura Pharmaceuticals
The New Generic-Drug Battle Front
Motley Fool
Saturday, May 18, 2013 - 12:15pm
tags:
generics
Oncothyreon A Speculative Buy
Seeking Alpha
Saturday, May 18, 2013 - 12:13pm
tags:
Oncothyreon
3 Most Important Upcoming FDA Decisions of 2013 (
Motley Fool
Saturday, May 18, 2013 - 12:12pm
tags:
FDA, Merck, GSK, Antares
Novartis AG (NVS): Today's Featured Drugs Laggard
The Street
Saturday, May 18, 2013 - 12:10pm
tags:
Novartis
Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Winner
The Street
Saturday, May 18, 2013 - 12:08pm
tags:
Bristol-Myers Squibb
J&J, Up 25% YTD, Shrugs Off Risperdal Suits
Yahoo/YCharts
Saturday, May 18, 2013 - 12:08pm
tags:
JNJ
J&J's DePuy to end 2 hip replacement systems
Yahoo/AP
Saturday, May 18, 2013 - 12:06pm
tags:
JNJ, DePuy, hip replacements, Ultamet, devices
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, May 18, 2013 - 11:54am
tags:
Infinity Pharmaceuticals, Gilead Sciences, SynaGeva BioPharma
IBD 50: Top 5 Medical Stocks Include Celgene, Actavis
Investors Business Daily
Saturday, May 18, 2013 - 11:53am
tags:
Actavis, Biogen, Celgene, Medicines Company, Illumina
Here's Why Amgen Shares Are Worth $117 To $126 Today
Seeking Alpha
Saturday, May 18, 2013 - 11:51am
tags:
Amgen
Progenics Pharmaceuticals Added to the NASDAQ Biotechnology Index
Yahoo/GlobeNewsWire
Saturday, May 18, 2013 - 11:48am
tags:
Progenics Pharmaceuticals
Celgene Corporation (CELG): Today's Featured Health Care Winner
The Street
Saturday, May 18, 2013 - 11:47am
tags:
Celgene
Bronstein, Gewirtz & Grossman, LLC Announces That A Class Action Has Been Filed Against Amyris, Inc.
Yahoo/PR Newswire
Saturday, May 18, 2013 - 11:46am
tags:
Amyris, lawsuits
Puma Biotech Gains After Rival Drug Data Show No Threat
Bloomberg
Saturday, May 18, 2013 - 11:43am
tags:
Puma Biotechnology, neratinib, breast cancer, cancer
Novo Nordisk completes PhIII hemophilia trial with positive results
Fierce Biotech
Friday, May 17, 2013 - 12:01pm
tags:
Novo Nordisk, hemophilia B, N9-GP
Sanofi, France remain at odds over fate of 600 R&D jobs
Fierce Pharma
Friday, May 17, 2013 - 11:56am
tags:
Sanofi, France, R&D

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.